Several investigations have demonstrated that diabetes downregulated the expression and function of intestinal PepT1 in experimental animals [47,97,98,99], decreasing oral plasma exposures of cephalexin and acyclovir following oral dose of cephalexin and valacyclovir [99]. The gene discussed is SLC15A1; the disease is diabetes mellitus.